Lisa Earnhardt

EVP, Medical Devices at Abbott. Also proud Mom, Wife, Daughter, Sister, Aunt, Friend.

[Lisa Earnhardt @LisaEarnhardt]

Amazing to see @Drdevignair in action—incredible teamwork, efficiency and unrelenting focus on her patients. A masterclass!

[Dr. Devi G Nair @Drdevignair]

It was a pleasure hosting Lisa Earnhardt , during her visit to our St Bernards Healthcare EP lab and @ARGJonesboro Research Group .
We had the opportunity to showcase several of Abbott’s advanced EP technologies, including the Volt PFA system, EnSite X mapping system, and the ViewFlex X SE catheter with integrated ICE imaging, highlighting integrated workflows in the EP lab.

We also discussed Aveir leadless pacemaker workflows focused on optimizing safety, efficacy, any procedural efficiency.
These technologies continue to enhance visualization, workflow efficiency, and precision in the EP lab, helping teams deliver better care for patients with complex arrhythmias.
Visits like these are always valuable, they highlight how collaboration between clinical teams and industry partners continues to advance patient-centered cardiac care and electrophysiology innovation.
#Electrophysiology #Abbott #VoltPFA #EnSiteX #ICEImaging #Aveir @AbbottCardio

[Abbott Cardiovascular @AbbottCardio]

📰BREAKING: Our #VoltPFA System has received CE Mark in Europe!

Read the press release: https://t.co/spIHANQ3qZ

CAUTION–This product is limited by U.S. Federal Law to investigational use. Product is not approved globally and may not be available in your market.

[Lisa Earnhardt @LisaEarnhardt]

#AbbottProud of our ongoing commitment to clinical evidence.

[JACC Journals @JACCJournals]

#AHA24: Dr. @DJ_Lakkireddy and team present results from Amulet IDE--the largest randomized #LAAO clinical trial to date-demonstrating long term safety & effectiveness of the Amulet occluder & Watchman device https://t.co/6vB9OXID0F #JACC

[Lisa Earnhardt @LisaEarnhardt]

Go @NorthwesternU! #AbbottProud

[Abbott @AbbottNews]

B1G News. 🏈

We teamed up with @BigTen to tackle the U.S. blood shortage with a conference-wide blood donation competition. Students, alumni and fans can now donate blood for their schools and help save lives.

Help your school win: https://t.co/bakDSIoQsS #WeGiveBlood

[Lisa Earnhardt @LisaEarnhardt]

Excited to help more people take control of their personal health journey with Lingo! #AbbottProud

[Abbott @AbbottNews]

It’s here – Meet Lingo, our biowearable with personal coaching that can help you see how your glucose responds to everyday life. Now available in the United States: https://t.co/PRfk8m4R89

[Lisa Earnhardt @LisaEarnhardt]

#AbbottProud

[Abbott @AbbottNews]

Depression impacts millions. Now, we're working on health tech to fight it.

We’ve initiated our TRANSCEND clinical study to evaluate the use of deep brain stimulation to manage treatment-resistant depression, a type of major depressive disorder. https://t.co/uUDUyxvQ2b

[Lisa Earnhardt @LisaEarnhardt]

World-leading sensing technology + world-leading insulin delivery systems = next-level diabetes care. #AbbottProud

[Abbott @AbbottNews]

BREAKING: We’re advancing diabetes care through a global partnership with @MDT_Diabetes to connect a continuous glucose monitor (CGM) based on our most advanced FreeStyle Libre tech with Medtronic’s insulin delivery systems. https://t.co/KZ25YvBK00

[Lisa Earnhardt @LisaEarnhardt]

#Abbottproud to be bringing a first-of-its-kind treatment option for people living with chronic limb-threatening ischemia below-the-knee

[Abbott @AbbottNews]

Our Esprit BTK System, now FDA-approved, was designed to disappear over time. 👇

It’s made with naturally dissolving materials and a medicine that keep the artery open and prevent reclosure while it's healing. https://t.co/ieKTvVKii6​

ISI: https://t.co/ahnY8huPyi

[Lisa Earnhardt @LisaEarnhardt]

@DrNatStrand Congratulations @DrNatStrand!

[Abbott @AbbottNews]

Our 2023 #earnings results show we’re stronger now than before the pandemic, and we’re forecasting another year of top-tier growth in 2024. More on $ABT earnings: https://t.co/wBGXLHR6W4

[Abbott @AbbottNews]

Spotted: A new duo for diabetes care.

For the first time, FreeStyle Libre tech users in the U.S. can have their continuous glucose monitor and insulin pump work together to help manage diabetes. https://t.co/Yf5uBmmwsq

[Lisa Earnhardt @LisaEarnhardt]

@Drdevignair @AbbottCardio @StBernards Thanks for your leadership on leadless pacing! Fortunate to work with #epeeps like you, setting the pace for things to come.

[Lisa Earnhardt @LisaEarnhardt]

@MonicaYLo @ArHeartHospital Congrats and thank you for your partnership as we advance leadless pacing options! Fortunate to work with #epeeps like you!

[Abbott Cardiovascular @AbbottCardio]

We're honored to see our #AVEIR DR Dual Chamber Leadless #Pacemaker included in @TIME’s Best Inventions of 2023! Explore how this revolutionary #MedTech is shaping the future of leadless pacing: https://t.co/YqAnkcfudD

Safety Info: https://t.co/GKtZ7WHDjS

#TIMEBestInventions

[Abbott Cardiovascular @AbbottCardio]

Take advantage of this unique opportunity to be part of #TMVR and #TEER data releases during the #TCT2023 conference! We will share key findings, in-depth study analysis, and more!

Add events to your calendar: https://t.co/0kVLIAF0ou

[MenloSchoolAthletics @MenloKnights]

Menlo vs Menlo-Atherton under way. Jack Earnhardt recovers onside kickoff!

[Lisa Earnhardt @LisaEarnhardt]

We’re working tirelessly to transform the standard of care for people with cardiovascular disease! #AbbottProud

[Abbott @AbbottNews]

The heart: Setting the pace for the human body.
Us: Setting the pace in heart tech.
https://t.co/jcp00DtElJ

[Lisa Earnhardt @LisaEarnhardt]

#AbbottProud of our teams across our Medical Devises businesses who remain focused on our strategy to drive forward patient-first innovation that is truly life-changing for more people who need it.

[Abbott @AbbottNews]

Through new products and expanded reimbursement coverage, we’re driving innovation and expanding access to our life-changing technologies. More on $ABT #earnings: https://t.co/xxhqVgybY2

[Lisa Earnhardt @LisaEarnhardt]

Pleasure to share how we @AbbottNews are attracting tech talent to solve cool engineering challenges AND do work that makes a difference in people’s health.

[Heidrick & Struggles @Heidrick]

Tune in to our newest #podcast episode featuring Lisa Earnhardt, EVP of medical devices at @AbbottNews. Discover her insights on #talent in the health tech industry, the skill sets needed, and opportunities to shape future #health innovation: https://t.co/bWX4TvGOib. #healthtech

[American College of Cardiology @ACCinTouch]

#FDAUpdate: @US_FDA approved on July 5 the first-ever dual-chamber leadless pacemaker system, developed by Abbott. The decision comes following the release of late-breaking clinical data presented at #HRS2023 & published in @NEJM. Learn more ➡️ https://t.co/l4w4rfDhoB